Abraxane for Injectable Suspension 100 mg

Abraxane for Injectable Suspension 100 mg is a powder for suspension used in intravenous therapy. This formulation contains paclitaxel, a chemotherapy agent, and is manufactured by Bristol-Myers Squibb Canada.

Abraxane for Injectable Suspension 100 mg is primarily used in cancer treatment. It is often administered as part of a chemotherapy regimen to target various types of cancer cells. The suspension is designed for intravenous infusion, allowing the active ingredient, paclitaxel, to be delivered directly into the bloodstream. This method aims to maximize the drug's effectiveness in combating cancer cells.

Common effects of Abraxane for Injectable Suspension 100 mg may include fatigue, nausea, and hair loss. Some individuals may also experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary in severity and duration depending on the individual and the specific treatment plan.

Abraxane for Injectable Suspension 100 mg should be handled with care, as it is a potent medication. It is important to follow the instructions provided by a healthcare professional regarding storage, preparation, and administration. The suspension should be prepared and administered in a controlled environment to ensure safety and efficacy. Always inform your healthcare provider about any existing medical conditions or allergies before starting treatment.

Abraxane for Injectable Suspension 100 mg may interact with other medications, including those that affect the liver or blood cells. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods or supplements may affect the drug's effectiveness, so it is advisable to follow a healthcare provider's guidance on diet and supplements during treatment.